I'm excited to be leading our MSL team now here at #GuardantHealth and am HIRING! *TWO* open remote MSL roles - we work closely with clinicians, conduct research, work cross-functionally and endlessly nerd out. Let's chat! linkedin.com/feed/update/ur… #GeneChat #hiring #MSL

Exciting work! Thanks for presenting on the team's behalf!

When you burn people out, you push them out. Stars are the first to leave—they have the most opportunities. The solution is not to pile on the perks. It’s to pinpoint the root causes of overload and design more manageable jobs. If you want to keep people, stop exhausting them.

Less than 40% of US workplaces offer >3 days of paid bereavement. It's time for compassionate leave: -More paid days: no one should have to work the week they lose a loved one -Nonconsecutive days: grief isn't linear -More coverage: beyond immediate family; include pregnancy

MSI-H as a biomarker has come so far from when I started in (germline) genetics clinic. Loved leading this work alongside an esteemed group of clinicians and publish ctDNA's reliable ability to rapidly identify patients who may benefit from IO. What's next?! Onward!! 🚀

👇🏾very cool study Annals of Oncology. Future of #LiquidBiopsies is multi-omics. This is what the group has done. Why just look at the cancer with one lens when you can do: ✔️Genomics ✔️Epigenomics ✔️Fragmentomics ✔️Proteomics OncoAlert International Society of Liquid Biopsy annalsofoncology.org/article/S0923-…

Walking around NSGC last week I couldn't but help think (many times) "I miss my friend." 💙 Learn more / donate here: nsgc.org/LaurenRyanGene…

The Midwest urge to say “it’s warm out” when it’s 30° instead of 3°

Pet grief is real. 💙 Grateful for Jon for sharing about Dipper. Honored to have also had one of "the best" of "the good boys" who's surely playing with Dipper now.

the bell all of Cleveland is glad to hear! Congrats Jimmy!!!

We are on our way to closing the #ColorectalCancer screening gap with our Shield blood test. Results of our 20,000-patient ECLIPSE study are now published in NEJM, reinforcing the validity of the test. Read more: investors.guardanthealth.com/press-releases…

HUGE congrats to my Guardant Health colleagues who’ve worked to develop, iterate, study, and publish (in NEJM!) a blood-based test for #ColorectalCancer screening. Such exciting data that adds to add’l studies on adherence. Let’s close that screening gap!

the accuracy

👏👏👏👏 Thank you to all of our brilliant collaborators - many here - who helped us reach this milestone! Onward!!

amazing views & good reminder to work to “see the whole elephant”

How can you NOT be an FCC fan?! 🤩

As a millennial… On behalf of my community, we are TIRED of experiencing historical events … Like a global IT outrage Regards, The tired millennials

🙌🙌🙌

What a great day for patients!

🚨📣🩸participate on the first global survey on attitudes, practices & barriers to #LiquidBiopsy use among clinical oncologists! 🌍 International Society of Liquid Biopsy It takes just 10 minutes⏰ and it will help to shape the future of cancer care! 👉 docs.google.com/forms/d/e/1FAI…